Letter regarding the article, “A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”
Ling-Yue Zhao, Yi-Jun Luo, Jing Zhu Department of Ambulatory Surgery, Shenzhen Nanshan District People’s Hospital, Shenzhen, Guangdong 518052, People’s Republic of China Previous studies have confirmed the utility of canrenone to control inflammation, microalbuminuria,...
Main Authors: | Zhao LY, Luo YJ, Zhu J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/letter-regarding-the-article-a-randomized-double-blind-clinical-trial--peer-reviewed-article-DDDT |
Similar Items
-
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients
by: Derosa G, et al.
Published: (2018-08-01) -
The statistical analyses of the study “Sufentanil Sublingual Tablet System (SSTS) for the management of postoperative pain after major abdominal and gynecological surgery within an ERAS protocol: an observational study”[Letter]
by: Wang X, et al.
Published: (2019-09-01) -
Reply to Letter to the Editor Regarding Article: “Considering the Potential Benefits of Over-The-Counter Naloxone” [Response To Letter]
by: Evou KE, et al.
Published: (2021-07-01) -
Letter to the editor regarding “Rotavirus infection beyond the gut”
by: Orrico-Sánchez A, et al.
Published: (2019-03-01) -
Letter to the editor regarding the article “The use of Psychiatric Electroencephalography Evaluations Registry (PEER) to personalize pharmacotherapy”
by: Weina PJ, et al.
Published: (2017-10-01)